First Trust Advisors
CALA

First Trust Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

First Trust Advisors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,742
Closed -$365K – 2687
2021
Q2 		$365K Buy
8,742
+111
+1% +$4.88K ﹤0.01% 2339
2021
Q1 		$418K Buy
8,631
+693
+9% +$40.3K ﹤0.01% 2261
2020
Q4 		$780K Sell
7,938
-359
-4% -$31.5K ﹤0.01% 1991
2020
Q3 		$572K Buy
+8,297
New +$724K ﹤0.01% 1996

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors's CALA Position: Q3 2021 in Review

First Trust Advisors sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 8,742 shares — an estimated $365K sold.

First Trust Advisors first reported a position in CALA in Q3 2020 and held it in 4 quarters. The position peaked at $780K in Q4 2020. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • First Trust Advisors reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 8,742 Calithera Biosciences, Inc shares in Q3 2021, an estimated $365K.
  • First Trust Advisors first reported a position in Calithera Biosciences, Inc in Q3 2020 and held it in 4 quarters.
  • First Trust Advisors's Calithera Biosciences, Inc position peaked at $780K in Q4 2020.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.